COVID-19 test required for travel from the People’s Republic of China

December 31, 2022

Starting 12:01 AM ET on January 5, 2023, all air passengers two years and older originating from the People’s Republic of China will be required to get a test (such as a PCR test or an antigen self-test administered and monitored by a telehealth service or a licensed provider) no more than two days before their departure from the People’s Republic of China, Hong Kong, or Macau, and show a negative test result to the airline upon departure to Canada or the United States.

  • The requirement applies to these air passengers regardless of nationality and vaccination status.
  • The test is required for any passengers travelling from, and/or who have been in China (PRC), Hong Kong or Macao in the last 10 days when travelling to or connecting onward beyond Canada and the United States.
  • This will also apply to persons travelling from the People’s Republic of China via third country transit and to passengers connecting through Canada or the United States onward to further destinations in Canada or the United States.
  • Passengers will be required to provide a negative COVID-19 test if they have been in the PRC in the last 10 days no more than 2 days before their departure to Canada or the United States.
  • Passengers who tested positive more than 10 days before their departure flight, but no more than 90 days, can provide the airline with documentation of their prior positive test, in place of a negative test result.

Further, when arriving at Primary Inspection Kiosks and eGates, or when making a customs declaration using the optional Advance CBSA Declaration prior to arriving at airports in Canada, travellers will be asked if they have travelled to the People’s Republic of China, Hong Kong, or Macao in the last 10 days. If they have, Canada Border Services Agency Officers will provide them with additional public health information on transmission of COVID-19, personal protective measures and what to do if they develop symptoms of COVID-19.